Aortic stenosis: role of balloon aortic valvuloplasty

Usman Baber1, Annapoorna S Kini, Pedro R Moreno

  • 1Cardiac Catheterization Laboratory, Mount Sinai Medical Center, New York, NY 10029, USA.

Cardiology Clinics
|August 13, 2013
PubMed

Insights

Calcific aortic stenosis (AS), a common heart valve disease in older adults, affects nearly 4% of those 75+. Balloon aortic valvuloplasty (BAV) offers symptomatic relief and temporary hemodynamic stabilization for high-risk patients.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Valvular Heart Disease

Background:

  • Calcific aortic stenosis (AS) is the most prevalent form of aortic valve disease globally.
  • Its incidence rises significantly with increasing age, affecting nearly 4% of adults aged 75 and older.
  • Many patients with AS are unsuitable for surgery due to comorbidities or high-risk factors.

Purpose of the Study:

  • To highlight the role of balloon aortic valvuloplasty (BAV) in managing calcific aortic stenosis.
  • To discuss BAV as a palliative measure for symptomatic relief in high-risk patients.
  • To explore BAV's utility as a bridge to definitive valve replacement therapies.

Main Methods:

  • Review of current clinical practices and literature regarding balloon aortic valvuloplasty for AS.
  • Analysis of BAV's efficacy in providing temporary palliation and hemodynamic stabilization.
  • Evaluation of BAV's role in the treatment algorithm for severe aortic stenosis in non-surgical candidates.

Main Results:

  • Balloon aortic valvuloplasty (BAV) provides temporary symptomatic relief for patients with severe aortic stenosis.
  • BAV is a viable option for hemodynamic stabilization in select AS patients.
  • It serves as a crucial bridge therapy for patients awaiting surgical or transcatheter valve replacement.

Conclusions:

  • Balloon aortic valvuloplasty (BAV) remains an important therapeutic option for calcific aortic stenosis, particularly in elderly and high-risk populations.
  • BAV offers palliative benefits and hemodynamic support when surgery is not feasible.
  • Its role as a bridge to more definitive treatments is well-established.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...